|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
1 to 14
|
|
|
|
Other
|
|
|
|
2005-000658-56 20040177, 2004-41-4276, NCT00192673
|
|
|
|
|
|
|
|
Last Modified: 10/17/2008  First Published: 12/23/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
1 to 30
|
|
|
|
NCI
|
|
|
|
COG-AALL0232 NCT00075725, AALL0232
|
|
|
|
|
|
|
|
Last Modified: 10/17/2008  First Published: 1/24/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
1 to 9
|
|
|
|
NCI
|
|
|
|
COG-AALL0331 AALL0331, NCT00103285
|
|
|
|
|
|
|
|
Last Modified: 6/17/2008  First Published: 11/13/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
1 to 17
|
|
|
|
NCI
|
|
|
|
DFCI-05001 NCT00400946
|
|
|
|
|
|
|
|
Last Modified: 10/17/2008  First Published: 11/22/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
1 to 30
|
|
|
|
NCI
|
|
|
|
COG-AALL0434 AALL0434, NCT00408005
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
ID03-0124 NCT00452439
|
|
|
|
|
|
|
|
Last Modified: 10/17/2008  First Published: 11/6/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Active
|
|
|
|
Under 1 at diagnosis
|
|
|
|
NCI
|
|
|
|
COG-AALL0631 AALL0631, NCT00557193
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and under
|
|
|
|
NCI, Other
|
|
|
|
TOTXVI NCT00549848
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Over 1 and under 21
|
|
|
|
Other
|
|
|
|
T2005-003 NCT00440726
|
|
|
|
|
|
|
|
Last Modified: 10/17/2008  First Published: 11/22/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
2 to 31
|
|
|
|
NCI
|
|
|
|
COG-ADVL04P2 ADVL04P2, NCT00098839
|
|
|
|